Parathyroid Hormone for the Treatment of Humerus Fractures

Phase IV Study of the Effect of Parathyroid Hormone on Fractures of the Humerus

Hypothesis:

The investigators want to study whether parathyroid hormone improves healing of humerus after a fracture. The investigators will assess healing of the humerus with Constant score.

Inclusion Criteria:

• proximal humeral fracture eligible for conservative treatment.
• able to understand the protocol
• signs an informed consent

Exclusion Criteria:

• liver disease
• kidney disease
• severe osteoporosis
• malignant disease
• bone metabolic disease
• oral treatment with bisphosphonates during the last 3 months.
• treatment with Denosumab during the last 6 months.
• intravenous treatment with bisphosphonates during the last 12 months.